206 related articles for article (PubMed ID: 28270441)
1. Insulin sensitizer prevents and ameliorates experimental type 1 diabetes.
Valitsky M; Hoffman A; Unterman T; Bar-Tana J
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E672-E680. PubMed ID: 28270441
[TBL] [Abstract][Full Text] [Related]
2. Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats.
Sadek KM; Shaheen H
Pharm Biol; 2014 May; 52(5):591-6. PubMed ID: 24251869
[TBL] [Abstract][Full Text] [Related]
3. Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight.
Melander SA; Larsen AT; Karsdal MA; Henriksen K
Br J Pharmacol; 2024 Jun; 181(12):1829-1842. PubMed ID: 38378168
[TBL] [Abstract][Full Text] [Related]
4. Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
González-Mariscal I; Pozo-Morales M; Romero-Zerbo SY; Espinosa-Jimenez V; Escamilla-Sánchez A; Sánchez-Salido L; Cobo-Vuilleumier N; Gauthier BR; Bermúdez-Silva FJ
Biomed Pharmacother; 2022 Jan; 145():112361. PubMed ID: 34872800
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin-induced diabetic models in mice and rats.
Wu KK; Huan Y
Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.47. PubMed ID: 22294227
[TBL] [Abstract][Full Text] [Related]
6. Induced regulatory T cells suppress Tc1 cells through TGF-β signaling to ameliorate STZ-induced type 1 diabetes mellitus.
Zhou L; He X; Cai P; Li T; Peng R; Dang J; Li Y; Li H; Huang F; Shi G; Xie C; Lu Y; Chen Y
Cell Mol Immunol; 2021 Mar; 18(3):698-710. PubMed ID: 33446887
[TBL] [Abstract][Full Text] [Related]
7. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
8. Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
Um J; Jung N; Kim D; Choi S; Lee SH; Son Y; Park KS
Biochem Biophys Res Commun; 2018 May; 499(4):960-966. PubMed ID: 29626466
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.
Podojil JR; Genardi S; Chiang MY; Kakade S; Neef T; Murthy T; Boyne MT; Elhofy A; Miller SD
J Immunol; 2022 Aug; 209(3):465-475. PubMed ID: 35725270
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and diabetes.
Takiishi T; Gysemans C; Bouillon R; Mathieu C
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):419-46, table of contents. PubMed ID: 20511061
[TBL] [Abstract][Full Text] [Related]
11. Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant.
Gunawardana SC; Piston DW
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1043-55. PubMed ID: 25898954
[TBL] [Abstract][Full Text] [Related]
12. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
[TBL] [Abstract][Full Text] [Related]
13. Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes.
Mokhtari D; Welsh N
Clin Sci (Lond); 2009 Nov; 118(4):241-7. PubMed ID: 19886867
[TBL] [Abstract][Full Text] [Related]
14. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
[TBL] [Abstract][Full Text] [Related]
15. Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice.
Fu Z; Yuskavage J; Liu D
J Agric Food Chem; 2013 May; 61(18):4303-9. PubMed ID: 23578364
[TBL] [Abstract][Full Text] [Related]
16. Oral insulin (human, murine, or porcine) does not prevent diabetes in the non-obese diabetic mouse.
Pham MN; Gibson C; Rydén AK; Perdue N; Boursalian TE; Pagni PP; Coppieters K; Skonberg C; Porsgaard T; von Herrath M; Vela JL
Clin Immunol; 2016 Mar; 164():28-33. PubMed ID: 26821303
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin-Induced Diabetic Models in Mice and Rats.
Furman BL
Curr Protoc Pharmacol; 2015 Sep; 70():5.47.1-5.47.20. PubMed ID: 26331889
[TBL] [Abstract][Full Text] [Related]
18. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
20. Substance P preserves pancreatic β-cells in streptozotocin-induced type 1 diabetic mice.
Jung N; Um J; Kim DY; Dubon MJ; Byeon Y; Kim D; Son Y; Park KS
Biochem Biophys Res Commun; 2017 Sep; 491(4):958-965. PubMed ID: 28754588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
